Title
Duration of Oxaliplatin-Containing Adjuvant Therapy for Stage III Colon Cancer
Authoring Organization
Publication Month/Year
April 15, 2019
Supplemental Implementation Tools
Document Type
Guideline
External Publication Status
Published
Country of Publication
US
Target Patient Population
Patients with completely resected stage III colon cancer.
Target Provider Population
Medical oncologists, general surgeons, colorectal surgeons, surgical oncologists, and oncology advanced practice providers
Inclusion Criteria
Female, Male, Adult, Older adult
Health Care Settings
Ambulatory
Intended Users
Nurse, nurse practitioner, physician, physician assistant
Scope
Treatment
Diseases/Conditions (MeSH)
D003108 - Colonic Diseases
Keywords
colon cancer, colorectal cancer, oxaliplatin, Stage III Colon Cancer, Oxaliplatin-Containing Adjuvant Therapy
Source Citation
DOI: 10.1200/JCO.19.00281 Journal of Clinical Oncology 37, no. 16 (June 01, 2019) 1436-1447.